Antifibrotic constituents of Alnus firma on hepatic stellate cells

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 10, 2011, Pages 2906-2910

  Lee, Mina ^a   Lee, Mi Kyeong ^b   Kim, Young Choong ^a   Sung, Sang Hyun ^a  

^a Seoul National University   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Alnus firma; Antifibrotic activity; Betulaceae; Diarylheptanoid; HSC T6 cells; Triterpenoid

Indexed keywords

ALNUS FIRMA EXTRACT; COLLAGEN; HEPTANE DERIVATIVE; LUP 20(29) EN 2,28 DIOL 3 YL CAFFEATE; PLANT EXTRACT; TRITERPENOID; UNCLASSIFIED DRUG;

ALDER; ALNUS FIRMA; ARTICLE; BARK; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); DRUG ACTIVITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; FRACTIONATION; HUMAN; HUMAN CELL; LIVER FIBROSIS; PROTON NUCLEAR MAGNETIC RESONANCE; STELLATE CELL;

ALNUS; ANIMALS; CELL LINE; CELL PROLIFERATION; DIARYLHEPTANOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATIC STELLATE CELLS; INHIBITORY CONCENTRATION 50; LIVER CIRRHOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PLANT BARK; PLANT EXTRACTS; RATS;

ALNUS FIRMA; BETULACEAE;

EID: 79955570706     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.03.074     Document Type: Article

References (18)

1. S.L. Friedman J. Biol. Chem. 275 2000 2247
2. S.L. Friedman J. Hepatol. 38 2003 38
3. A.M. Gressner Kidney Int. Suppl. 54 1996 39
4. R. Sakata, T. Ueno, T. Nakamura, M. Sakamoto, T. Torimura, and M. Sata J. Hepatol. 40 2004 52
5. T.J. Kim Korean Resources Plants Vol. 1 1996 Seoul National University Press
6. Y.B. Yu, H. Miyashiro, N. Nakamura, M. Hattori, and J.C. Park Arch. Pharm. Res. 30 2007 820
7. Y. Asakawa Bull. Chem. Soc. Jpn. 43 1970 2223
8. M. Lee, H.K. Lee, S.H. Kim, Y.C. Kim, and S.H. Sung Planta Med. 76 2010 1007
9. A. Patra, S.K. Chaudhuri, and S.K. Panda J. Nat. Prod. 51 1988 217
10. I.K. Adnyana, Y. Tezuka, A.H. Banskota, K.Q. Tran, and S. Kadota J. Nat. Prod. 64 2001 360
11. P.M. Giang, P.T. Son, K. Matsunami, and H. Otsuka Chem. Pharm. Bull. 54 2006 139
12. K. Sunnerheim, and P.G. Knutsson J. Chem. Ecol. 21 1995 1339
13. M. Kuroyanagi, M. Shimomae, Y. Nagashima, N. Muto, T. Okuda, N. Kawahara, T. Nakane, and T. Sano Chem. Pharm. Bull. 53 2005 1519
14. 4 cells/mL] and incubated for 24 h. HSC-T6 cells were treated with vehicle or compounds to be tested for 48 h.
15. MTT assay was conducted by the incubation of HSC-T6 cells with 0.5 mg/mL of MTT in the last 2 h of the culture period tested. Reduction of MTT to formazan was assessed in an ELISA plate reader at 540 nm. The effect on cell proliferation was measured by BrdU incorporation assay according to manufacturer's protocol. Cell viability and cell proliferation (% of control) of compounds 1-13 on was calculated as 100 × (absorbance of treated compound/absorbance of control). Data were expressed as the mean of three independent experiments.
16. H. Tullberg-Reinert, and G. Jundt Histochem. Cell. Biol. 112 1999 271
17. C. Zheng, and A. Chen Biochem. J. 384 2004 149
18. Y.L. Lin, C.Y. Lin, C.W. Chi, and Y.T. Huang Phytother. Res. 23 2009 927